BRISTOL-MYERS SQUIBB COMPANY Gain (Loss) Related to Litigation Settlement
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Gain (Loss) Related to Litigation Settlement of -$5.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY gain (loss) related to litigation settlement for the quarter ending 2026-06-30 was -$5.00M.
- BRISTOL-MYERS SQUIBB COMPANY gain (loss) related to litigation settlement for the quarter ending 2026-03-31 was -$4.00M.
- BRISTOL-MYERS SQUIBB COMPANY gain (loss) related to litigation settlement for the quarter ending 2025-12-31 was -$10.00M.
- BRISTOL-MYERS SQUIBB COMPANY gain (loss) related to litigation settlement for the quarter ending 2025-09-30 was -$165.00M.
- BRISTOL-MYERS SQUIBB COMPANY gain (loss) related to litigation settlement for fiscal 2025 was -$434.00M.
- BRISTOL-MYERS SQUIBB COMPANY gain (loss) related to litigation settlement for fiscal 2024 was -$84.00M, a 121.54% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY gain (loss) related to litigation settlement for fiscal 2023 was $390.00M.
- BRISTOL-MYERS SQUIBB COMPANY gain (loss) related to litigation settlement for fiscal 2022 was -$178.00M.
| Period end | Gain (Loss) Related to Litigation Settlement 1 month | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month | Gain (Loss) Related to Litigation Settlement 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.00M 10-Q · filed 2026-07-30 | -$8.00M 10-Q · filed 2026-07-30 | -$19.00M derived: sum of 3 quarters · filed 2026-07-30 | -$184.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$4.00M 10-Q · filed 2026-04-30 | -$14.00M derived: sum of 2 quarters · filed 2026-04-30 | -$179.00M derived: sum of 3 quarters · filed 2026-04-30 | -$180.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$175.00M derived: sum of 2 quarters · filed 2026-02-11 | -$176.00M derived: sum of 3 quarters · filed 2026-07-30 | -$434.00M 10-K · filed 2026-02-11 | ||
| 2025-09-30 | -$165.00M 10-Q · filed 2025-10-30 | -$166.00M derived: sum of 2 quarters · filed 2026-07-30 | -$424.00M 10-Q · filed 2025-10-30 | -$436.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | -$1.00M 10-Q · filed 2026-07-30 | -$259.00M 10-Q · filed 2026-07-30 | -$271.00M derived: sum of 3 quarters · filed 2026-07-30 | -$271.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | -$257.00M 10-Q · filed 2026-04-30 | -$270.00M derived: sum of 2 quarters · filed 2026-04-30 | -$270.00M derived: sum of 3 quarters · filed 2026-04-30 | -$339.00M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | -$13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$13.00M derived: sum of 2 quarters · filed 2026-02-11 | -$82.00M derived: sum of 3 quarters · filed 2026-02-11 | -$84.00M 10-K · filed 2026-02-11 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-10-30 | -$69.00M derived: sum of 2 quarters · filed 2025-10-30 | -$71.00M 10-Q · filed 2025-10-30 | -$74.00M derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-06-30 | -$69.00M 10-Q · filed 2025-07-31 | -$71.00M 10-Q · filed 2025-07-31 | -$74.00M derived: sum of 3 quarters · filed 2026-02-11 | -$13.00M derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-03-31 | -$2.00M 10-Q · filed 2025-04-24 | -$5.00M derived: sum of 2 quarters · filed 2026-02-11 | $56.00M derived: sum of 3 quarters · filed 2026-02-11 | $63.00M derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2023-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $58.00M derived: sum of 2 quarters · filed 2026-02-11 | $65.00M derived: sum of 3 quarters · filed 2026-02-11 | $390.00M 10-K · filed 2026-02-11 | ||
| 2023-09-30 | $61.00M 10-Q · filed 2024-10-31 | $68.00M derived: sum of 2 quarters · filed 2024-10-31 | $393.00M 10-Q · filed 2024-10-31 | $247.00M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-06-30 | $7.00M 10-Q · filed 2024-07-26 | $332.00M 10-Q · filed 2024-07-26 | $186.00M derived: sum of 3 quarters · filed 2025-02-12 | $142.00M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-03-31 | $325.00M 10-Q · filed 2024-04-25 | $179.00M derived: sum of 2 quarters · filed 2025-02-12 | $135.00M derived: sum of 3 quarters · filed 2025-02-12 | $110.00M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2022-12-31 | -$146.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$190.00M derived: sum of 2 quarters · filed 2025-02-12 | -$215.00M derived: sum of 3 quarters · filed 2025-02-12 | -$178.00M 10-K · filed 2025-02-12 | ||
| 2022-09-30 | -$44.00M 10-Q · filed 2023-10-26 | -$69.00M derived: sum of 2 quarters · filed 2023-10-26 | -$32.00M 10-Q · filed 2023-10-26 | -$65.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | -$25.00M 10-Q · filed 2023-07-27 | $12.00M 10-Q · filed 2023-07-27 | -$21.00M derived: sum of 3 quarters · filed 2024-02-13 | -$34.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-03-31 | $37.00M 10-Q · filed 2023-04-27 | $4.00M derived: sum of 2 quarters · filed 2024-02-13 | -$9.00M derived: sum of 3 quarters · filed 2024-02-13 | -$53.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | -$33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$46.00M derived: sum of 2 quarters · filed 2024-02-13 | -$90.00M derived: sum of 3 quarters · filed 2024-02-13 | -$82.00M 10-K · filed 2024-02-13 | ||
| 2021-09-30 | -$13.00M 10-Q · filed 2022-10-26 | -$57.00M derived: sum of 2 quarters · filed 2022-10-26 | -$49.00M 10-Q · filed 2022-10-26 | $186.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | -$44.00M 10-Q · filed 2022-07-27 | -$36.00M 10-Q · filed 2022-07-27 | $199.00M derived: sum of 3 quarters · filed 2023-02-14 | $189.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | $8.00M 10-Q · filed 2022-04-29 | $243.00M derived: sum of 2 quarters · filed 2023-02-14 | $233.00M derived: sum of 3 quarters · filed 2023-02-14 | $234.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | $235.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $225.00M derived: sum of 2 quarters · filed 2023-02-14 | $226.00M derived: sum of 3 quarters · filed 2023-02-14 | $194.00M 10-K · filed 2023-02-14 | ||
| 2020-09-30 | -$10.00M 10-Q · filed 2021-10-27 | -$9.00M derived: sum of 2 quarters · filed 2021-10-27 | -$41.00M 10-Q · filed 2021-10-27 | -$118.00M derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2020-06-30 | $1.00M 10-Q · filed 2021-07-28 | -$31.00M 10-Q · filed 2021-07-28 | -$108.00M derived: sum of 3 quarters · filed 2022-02-09 | -$107.00M derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2020-03-31 | -$32.00M 10-Q · filed 2021-04-29 | -$109.00M derived: sum of 2 quarters · filed 2022-02-09 | -$108.00M derived: sum of 3 quarters · filed 2022-02-09 | -$108.00M derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2019-12-31 | -$77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$76.00M derived: sum of 2 quarters · filed 2022-02-09 | -$76.00M derived: sum of 3 quarters · filed 2022-02-09 | -$77.00M 10-K · filed 2022-02-09 | ||
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-05 | $1.00M derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | -$66.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | -$1.00M 10-Q · filed 2020-08-06 | -$67.00M derived: sum of 3 quarters · filed 2021-02-10 | -$78.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-03-31 | -$1.00M 10-Q · filed 2020-05-07 | -$67.00M derived: sum of 2 quarters · filed 2021-02-10 | -$78.00M derived: sum of 3 quarters · filed 2021-02-10 | -$77.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2018-12-31 | -$66.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | -$77.00M derived: sum of 2 quarters · filed 2021-02-10 | -$76.00M derived: sum of 3 quarters · filed 2021-02-10 | -$76.00M 10-K · filed 2021-02-10 | ||
| 2018-09-30 | -$11.00M 10-Q · filed 2019-10-31 | -$10.00M derived: sum of 2 quarters · filed 2019-10-31 | -$10.00M 10-Q · filed 2019-10-31 | -$12.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-06-30 | $1.00M 10-Q · filed 2019-07-25 | $1.00M 10-Q · filed 2019-07-25 | -$1.00M derived: sum of 3 quarters · filed 2020-02-24 | -$1.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-25 | -$2.00M derived: sum of 2 quarters · filed 2020-02-24 | -$2.00M derived: sum of 3 quarters · filed 2020-02-24 | $3.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2017-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$2.00M derived: sum of 2 quarters · filed 2020-02-24 | $3.00M derived: sum of 3 quarters · filed 2020-02-24 | $487.00M 10-K · filed 2020-02-24 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $5.00M derived: sum of 2 quarters · filed 2018-10-25 | $489.00M 10-Q · filed 2018-10-25 | $490.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-06-30 | $5.00M 10-Q · filed 2018-07-26 | $489.00M 10-Q · filed 2018-07-26 | $490.00M derived: sum of 3 quarters · filed 2019-02-25 | $491.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-03-31 | $484.00M 10-Q · filed 2018-04-26 | $485.00M derived: sum of 2 quarters · filed 2019-02-25 | $486.00M derived: sum of 3 quarters · filed 2019-02-25 | $480.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2016-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $2.00M derived: sum of 2 quarters · filed 2019-02-25 | -$4.00M derived: sum of 3 quarters · filed 2019-02-25 | -$47.00M 10-K · filed 2019-02-25 | ||
| 2016-09-30 | $1.00M 10-Q · filed 2017-10-26 | -$5.00M derived: sum of 2 quarters · filed 2017-10-26 | -$48.00M 10-Q · filed 2017-10-26 | -$193.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-30 | -$6.00M 10-Q · filed 2017-07-27 | -$49.00M 10-Q · filed 2017-07-27 | -$194.00M derived: sum of 3 quarters · filed 2018-02-13 | -$192.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-03-31 | -$43.00M 10-Q · filed 2017-04-27 | -$188.00M derived: sum of 2 quarters · filed 2018-02-13 | -$186.00M derived: sum of 3 quarters · filed 2018-02-13 | -$190.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2015-12-31 | -$145.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$143.00M derived: sum of 2 quarters · filed 2018-02-13 | -$147.00M derived: sum of 3 quarters · filed 2018-02-13 | -$159.00M 10-K · filed 2018-02-13 | ||
| 2015-09-30 | $2.00M 10-Q · filed 2016-10-27 | -$2.00M derived: sum of 2 quarters · filed 2016-10-27 | -$14.00M 10-Q · filed 2016-10-27 | -$18.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-06-30 | -$4.00M 10-Q · filed 2016-07-28 | -$16.00M 10-Q · filed 2016-07-28 | -$20.00M derived: sum of 3 quarters · filed 2017-02-21 | -$30.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-03-31 | -$12.00M 10-Q · filed 2016-04-28 | -$16.00M derived: sum of 2 quarters · filed 2017-02-21 | -$26.00M derived: sum of 3 quarters · filed 2017-02-21 | -$6.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2014-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | -$14.00M derived: sum of 2 quarters · filed 2017-02-21 | $6.00M derived: sum of 3 quarters · filed 2017-02-21 | -$23.00M 10-K · filed 2017-02-21 | ||
| 2014-09-30 | -$10.00M 10-Q · filed 2015-10-27 | $10.00M derived: sum of 2 quarters · filed 2015-10-27 | -$19.00M 10-Q · filed 2015-10-27 | -$44.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-06-30 | $20.00M 10-Q · filed 2015-07-23 | -$9.00M 10-Q · filed 2015-07-23 | -$34.00M derived: sum of 3 quarters · filed 2016-02-12 | -$51.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-03-31 | -$29.00M 10-Q · filed 2015-04-28 | -$54.00M derived: sum of 2 quarters · filed 2016-02-12 | -$71.00M derived: sum of 3 quarters · filed 2016-02-12 | -$49.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2013-12-31 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$42.00M derived: sum of 2 quarters · filed 2016-02-12 | -$20.00M derived: sum of 3 quarters · filed 2016-02-12 | -$20.00M 10-K · filed 2016-02-12 | ||
| 2013-09-30 | -$17.00M 10-Q · filed 2014-10-24 | $5.00M derived: sum of 2 quarters · filed 2014-10-24 | $5.00M 10-Q · filed 2014-10-24 | |||
| 2013-06-30 | $22.00M 10-Q · filed 2014-07-24 | $22.00M 10-Q · filed 2014-07-24 | ||||
| 2012-12-31 | -$55.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$105.00M derived: sum of 2 quarters · filed 2015-02-13 | -$127.00M derived: sum of 3 quarters · filed 2015-02-13 | $45.00M 10-K · filed 2015-02-13 | ||
| 2012-09-30 | -$50.00M 10-Q · filed 2013-10-23 | -$72.00M derived: sum of 2 quarters · filed 2013-10-23 | $100.00M 10-Q · filed 2013-10-23 | |||
| 2012-06-30 | -$22.00M 10-Q · filed 2013-07-25 | $150.00M 10-Q · filed 2013-07-25 | ||||
| 2012-03-31 | $172.00M 10-Q · filed 2013-04-25 | |||||
| 2011-12-31 | -$6.00M 10-K · filed 2014-02-14 | $25.00M 10-K · filed 2012-02-17 | ||||
| 2010-12-31 | $2.00M 10-K · filed 2013-02-15 | |||||
| 2010-09-30 | $27.60M 10-Q · filed 2010-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |